chemotherapy

Case Report
Citric Acid Treatment of Refractory Chronic Postmastectomy Raw Area During Chemotherapy: A Novel Approach
09/24/2024
The current study reports the use of a simple, yet effective, novel treatment option for refractory chronic postoperative raw area in a surgical case of breast carcinoma.
The current study reports the use of a simple, yet effective, novel treatment option for refractory chronic postoperative raw area in a surgical case of breast carcinoma.
The current study reports the...
09/24/2024
Wounds
Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know
Review
Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know
03/27/2021
Types, indications, and common regimens of systemic forms of therapy offered in early-stage breast cancer are reviewed, with further detail on the mechanism of action, approved uses, major toxicities, and relevance to breast reconstruction of...
Types, indications, and common regimens of systemic forms of therapy offered in early-stage breast cancer are reviewed, with further detail on the mechanism of action, approved uses, major toxicities, and relevance to breast reconstruction of...
Types, indications, and common...
03/27/2021
ePlasty
Use of Negative Pressure Wound Therapy with Instillation and Dwell Times for Complex Wound Management in a Cancer Care Setting
Introduction: Wound management represents a major healthcare cost and with inadequate intervention has a significant impact on patient quality of life. Oncological wounds have a delayed r...
06/10/2019
Research in Review
Chemotherapy May Be Overused Among Patients With Colon Cancer
02/09/2017
JCP Editors
Chemotherapy may be overused among young and middle-aged patients with colon cancer, according to a study published in JAMA Surgery (published online January 25, 2017; doi: 10.1001/jamasurg.2016.5050). ----- Related...
Chemotherapy may be overused among young and middle-aged patients with colon cancer, according to a study published in JAMA Surgery (published online January 25, 2017; doi: 10.1001/jamasurg.2016.5050). ----- Related...
...
02/09/2017
Journal of Clinical Pathways
Research in Review
PET Scans During Induction Chemo Contribute to Complete Response for Esophageal Cancer
01/19/2017
JCP Editors
Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate...
Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate...
...
01/19/2017
Journal of Clinical Pathways
Research in Review
Two-Drug Regimen Without Chemotherapy May Treat Type of Lymphoma
01/06/2017
JCP Editors
Patients with mantle cell lymphoma may be able to forego chemotherapy in favor of induction treatment with a two-drug regimen, according to new research presented at the American Society of Hematology (ASH) annual...
Patients with mantle cell lymphoma may be able to forego chemotherapy in favor of induction treatment with a two-drug regimen, according to new research presented at the American Society of Hematology (ASH) annual...
...
01/06/2017
Journal of Clinical Pathways
Research in Review
First-Line Pembrolizumab for NSCLC Improves HRQoL Versus Chemotherapy
12/08/2016
JCP Editors
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing...
...
12/08/2016
Journal of Clinical Pathways
Research in Review
Pembrolizumab Better Than Chemotherapy for Urothelial Cancer
11/14/2016
JCP Editors
An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...
An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...
An...
11/14/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use